-
Tirofiban, sold
under the
brand name Aggrastat, is an
antiplatelet medication. It
belongs to a
class of
antiplatelets named glycoprotein IIb/IIIa inhibitors...
-
inhibitors exist:
abciximab (abcixifiban) (ReoPro)
eptifibatide (Integrilin)
tirofiban (Aggrastat)
roxifiban orbofiban Glycoprotein IIb/IIIa
inhibitors are frequently...
-
receptor is a
target of
several drugs including abciximab, eptifibatide, and
tirofiban. Once
platelets are activated,
granules secrete clotting mediators, including...
-
inhibitors (intravenous use only)
Abciximab (ReoPro)
Eptifibatide (Integrilin)
Tirofiban (Aggrastat)
Irreversible cyclooxygenase inhibitors Aspirin Triflusal (Disgren)...
-
medications clopidogrel, cefoperazone,
valproic acid, cefotetan, eptifibatide,
tirofiban, and ticlopidine.
Anticoagulants and
thrombolytic medications also increase...
-
Desmopressin Factor VIIa
Thrombopoietin mimetics Abciximab Eptifibatide Tirofiban Others: oprelvekin, romiplostim, eltrombopag,
argatroban Platelet transfusion...
- hirudin. Yet
another drug
produced from E.
carinatus venom is
Aggrastat (
Tirofiban). As of
November 2016,
antivenom is
currently being developed by the Costa...
- of the
platelet glycoprotein αIIbβ3a
receptor such as
eptifibatide or
tirofiban may be used.
There is
varying evidence on the
mortality benefits in NSTEMI...
-
acceptance after the
specific antibody abciximab and the non-peptide
tirofiban entered the
global market.
Eptifibatide is used to
reduce the risk of...
-
codon AGG
iShares Core
Total US Bond
Market ETF, an exchange-traded fund
Tirofiban,
trade name Aggrastat, an
antiplatelet drug People:
Alfred John Agg (1830–1886)...
